SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058718
Filing Date
2024-05-13
Accepted
2024-05-13 16:34:55
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20240331.htm   iXBRL 10-Q 2292162
2 EX-10.1 stro-ex10_1.htm EX-10.1 999957
3 EX-31.1 stro-ex31_1.htm EX-31.1 14459
4 EX-31.2 stro-ex31_2.htm EX-31.2 14570
5 EX-32.1 stro-ex32_1.htm EX-32.1 7147
6 EX-32.2 stro-ex32_2.htm EX-32.2 7177
  Complete submission text file 0000950170-24-058718.txt   10456682

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240331.xsd EX-101.SCH 1498426
75 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240331_htm.xml XML 1604858
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 24939657
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)